Supplement Science Blog | Everbright Labs
autophagycardiovascular healthclinical trialscognitive healthhealthy ageinglongevity supplementsspermidinespermidine supplement clinical studies
Spermidine supplement clinical studies on safety and evidence
The early clinical safety findings are reassuring, though limited in duration. In a placebo-controlled trial, 37 healthy men aged 50-70 received 40 mg/day of high-purity spermidine trihydrochloride for up to 28 days, wit…
Read moreabout Spermidine supplement clinical studies on safety and evidence